Combined Hormonal Contraceptives (CHCs) Study Shows Risk of Cardiovascular Disease.

Bookmark and Share  

- FDA

10/27/2011 - The FDA has released a PDF showing the results of a recent study of oral contraceptives such as Yaz, Yasmin and Ocella and found that those that contained the hormone drospirenone carried an increased risk of blood clots and other cardiovascular events when compared to other contraceptives that did not contain drospirenone. The PDF containing the details of their findings can be viewed by clicking the link below.

Click here to view PDF::

Yaz / Yasmin / Ocella Lawsuit News Archive::

If you or a loved one have suffered serious yaz side effects, injury or death while using Yaz you may be entitled to compensation. Contact the yaz side effects lawyers of Ennis & Ennis, P.A. today for a free nationwide case evaluation. Our experienced Yaz attorneys can answer any questions you may have about Yaz side effects or a potential Yaz lawsuit. Fill out the case evaluation form at ennislaw.com  or call toll free: 1.800.856.6405.

Under no circumstances should you discontinue taking any medication, including Yaz or one the generic versions, without first consulting with your doctor.

 

What did you think of this article?




Trackbacks
  • No trackbacks exist for this post.
Comments
  • No comments exist for this post.
Leave a comment

Submitted comments are subject to moderation before being displayed.

 Name

 Email (will not be published)

Your comment is 0 characters limited to 3000 characters.